07

Aug

2025

00:00

BST

Webinar

06

Aug

2025

18:00

CT

Navigating Mitral and Tricuspid Valve Disease: Diagnosis, Quality of Life, and Patient-Centered Care

00

Days

00

Hours

00

Mins

00

Secs

Reserve your Seat
Navigating Mitral and Tricuspid Valve Disease: Diagnosis, Quality of Life, and Patient-Centered Care

Faculty:


Suzanne Arnold

Suzanne Arnold


Colin Barker

Colin Barker

Reserve your Seat

Overview

Mitral and tricuspid regurgitation remain under-recognised and undertreated despite their significant impact on symptoms, quality of life, and outcomes. In this expert-led webinar, Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) offers practical guidance on recognising heart valve disease early, navigating referral pathways, and integrating patient-centred data into everyday cardiology practice.

The session opens with a focus on identifying symptoms and understanding when to refer to a heart team, highlighting gaps in diagnosis and treatment. Dr Arnold then explores how untreated mitral and tricuspid regurgitation can affect prognosis and quality of life, with a detailed look at available medical, surgical, and transcatheter therapies.

A key feature of this webinar is the use of real-world quality-of-life and patient preference data. Suzanne V. Arnold, MD (Saint Luke’s Health System, Kansas City, US) shares how general cardiologists can use these insights to hold meaningful shared decision-making conversations that improve engagement and treatment satisfaction.

Designed for general cardiologists and heart team members, this session offers clinical context, practical tools, and actionable strategies to improve outcomes in valve disease care. A live Q&A will provide the opportunity to explore key issues with the faculty.

Register now to gain expert guidance on delivering patient-centred, high-quality valve care.

This webinar is supported by Edwards Lifesciences. All speakers are paid consultants of Edwards Lifesciences.

Agenda

Session 1: Recognizing and Responding to Mitral Regurgitation & Tricuspid Regurgitation

Symptoms and clinical impact of mitral, tricuspid regurgitation
Addressing the care gap: under diagnosis and under treatment
When and how to refer to the heart team

Q&A + Discussion

Suzanne V. Arnold, MD and Colin Barker, MD

Session 2: Progression and Treatment Options

Discuss the repercussions of untreated mitral and tricuspid regurgitation
Explore treatment options including medical therapy, surgery, and transcatheter therapies
Review optimal referral timing and pathways

Q&A + Discussion

Suzanne V. Arnold, MD Suzanne V. Arnold, MD and Colin Barker, MD

Session 3: Quality of Life and Patient Preferences

Review contemporary data regarding quality of life and patient preferences specific to transcatheter therapies
Share ways that Clinical Cardiologists can use patient-centered data in their practices
Engage heart valve disease patients in meaningful shared decision-making conversations

Q&A + Discussion

Suzanne V. Arnold, MD Suzanne V. Arnold, MD and Colin Barker, MD

Learning Objectives

  • Understand symptoms and impact of mitral and tricuspid regurgitation, referral indications, and address underdiagnosis, under-referral, and undertreatment in heart valve disease
  • Explore the impact of untreated mitral and tricuspid regurgitation on outcomes and review referral timing and treatment options, including medical, surgical, and transcatheter therapies
  • Present quality-of-life and patient preference data for mitral and tricuspid regurgitation, and how general cardiologists can use these insights to support shared decision-making

Target Audience

  • Cardiologists

Faculty Biographies


Suzanne Arnold

Suzanne Arnold

Suzanne Arnold, MD, is a board-certified and fellowship trained cardiologist with Saint Luke's Cardiovascular Consultants.

View full profile

Colin Barker

Colin Barker

Colin Barker, MD, is Director of Interventional Cardiology and Associate Professor of Medicine at Vanderbilt University Medical Center. Colin Barker, MD specialises in complex coronary interventions, structural heart therapies and peripheral vascular disease. His r

View full profile